We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Indivior Plc | LSE:INDV | London | Ordinary Share | GB00BN4HT335 | ORD USD0.50 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-11.00 | -0.65% | 1,694.00 | 1,709.00 | 1,711.00 | 1,720.00 | 1,699.00 | 1,708.00 | 478,486 | 16:35:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.09B | 2M | 0.0148 | 1,154.05 | 2.31B |
TIDMINDV
RNS Number : 8416G
Indivior PLC
30 November 2020
Indivior is providing the following statement pursuant to its initial statement dated November 27, 2020, related to a claim filed against it by Reckitt Benckiser Group.
Indivior PLC ("Indivior" or "the Company"), as an entitled party, has reviewed the claim Reckitt Benckiser Group ("RB") filed against the Company in the Commercial High Court in London on November 13, 2020. At the present time, the claim has not been served on the Company. Indivior notes reported comments by RB, as published in The Times and Financial Times newspapers on November 27, 2020, that RB "regularly takes certain procedural steps to preserve potential claims."
Based on the information available to it, Indivior strongly believes that the claim is without merit and that it has strong grounds for defending against the claim should it be served. If the claim is served, Indivior will fully and vigorously defend itself in any proceedings related to the claim.
Indivior will make further announcements as appropriate, including in relation to whether the claim is served.
For Further Information
Investor Enquiries Jason Thompson VP, Investor +1 804 402 7123 Relations Indivior jason.thompson@indivior.com PLC Media Enquiries Jonathan Sibun Tulchan Communications +44 207 353 4200 US Media Inquiries +1 804 594 0836 Indiviormediacontacts@indivior.com
-ends-
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
FURBLBMTMTITTTM
(END) Dow Jones Newswires
November 30, 2020 02:00 ET (07:00 GMT)
1 Year Indivior Chart |
1 Month Indivior Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions